GlassScriptPhysician profile
Hua J Chen
NPI 1033237284
$7,090.89
in general payments reported to CMS, 2019-2025
44 companies · $658 in 2025
The $658 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $592 · 2021: $1,090 · 2022: $1,699 · 2023: $1,655 · 2024: $875 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,916 · Consulting Fee: $150 · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,916.41 |
| Consulting Fee | $150.00 |
| Education | $122.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,171.26 | 2020-2025 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $949.21 | 2019-2025 | |
| Emd Serono, INC. | $570.05 | 2019-2025 | Mavenclad |
| Abbvie INC. | $329.65 | 2021-2025 | Qulipta, Ubrelvy |
| Ucb, INC. | $315.08 | 2021-2025 | Briviact, Rystiggo |
| Pfizer INC. | $305.00 | 2023-2025 | |
| Sk Life Science, INC. | $294.75 | 2021-2025 | |
| Celgene Corporation | $271.56 | 2021-2024 | Zeposia |
| Neurocrine Biosciences, INC. | $245.07 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $215.42 | 2019-2025 | Ajovy, Austedo Xr |
| Amgen INC. | $196.13 | 2019-2023 | Aimovig |
| Biohaven Pharmaceutical Holding Company LTD. | $187.58 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $177.35 | 2021 | |
| Eisai INC. | $170.66 | 2019-2025 | |
| Genzyme Corporation | $158.15 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hua Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.